POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF KANGINTI 150 MG SOLUTION FOR INFUSION, 1 PIECE
Turkey·Pharmaceutical Product·AMGEN İLAÇ TİC. LTD. ŞTİ.·Licensed Dec 22, 2020- Product ID (UID)
- 7ab6dd80a1a1abcce6d6e72707d7babd
- License Number
- 2020/270
- Barcode
- 8699862270038
- ATC Code
- L01FD01
- License Holder
- AMGEN İLAÇ TİC. LTD. ŞTİ.
- Active Ingredient (EN)
- trastuzumab
- License Date
- Dec 22, 2020
Access comprehensive regulatory information for POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF KANGINTI 150 MG SOLUTION FOR INFUSION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 7ab6dd80a1a1abcce6d6e72707d7babd with license number 2020/270and contains active ingredient trastuzumab. The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..
This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.